Alcon AG DRC (A2LC34)

Currency in BRL
44.44
+4.56(+11.43%)
Closed·
Advertisement
Trading near 52-week High
A2LC34 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
44.4444.56
52 wk Range
39.8844.56
Key Statistics
Bid/Ask
33.45 / 44.56
Prev. Close
44.44
Open
44.56
Day's Range
44.44-44.56
52 wk Range
39.88-44.56
Volume
2
Average Volume (3m)
2
1-Year Change
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
A2LC34 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Currently not supported.
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 5 consecutive years

Earnings

Latest Release
10/11/2026
EPS / Forecast
0.54 / --
Revenue / Forecast
2.74B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 7.09
Dividend Yield
0.28%
Industry Median 1.18%
Annualised payout
0.11
Paid annually
5-Years Growth
+25.59%
Growth Streak

Compare A2LC34 to Peers and Sector

Metrics to compare
A2LC34
Peers
Sector
Relationship
P/E Ratio
54.0x27.1x−0.2x
PEG Ratio
−1.64−1.400.00
Price/Book
1.7x2.4x2.6x
Price / LTM Sales
3.3x3.1x2.7x
Upside (Analyst Target)
-6.0%72.2%
Fair Value Upside
Unlock7.0%12.4%Unlock

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Employees
25000
Market
Brazil

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
196.14M40.83%7.82B
Other Institutional Investors
81.38M16.94%3.25B
Public Companies & Retail Investors
202.88M42.23%8.09B
Total
480.4M100.00%19.16B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Vanguard Capital Management, LLC3.97%19,064,728760,301
Government Pension Fund Global2.40%11,542,930460,332

FAQ

What Is the Alcon DRC (B3: A2LC34) Share Price Today?

The Alcon DRC stock price today is 44.44 BRL.

What Stock Exchange Does Alcon DRC (A2LC34) Trade On?

Alcon DRC is listed and trades on the B3 Stock Exchange.

What Is the Ticker (Stock Symbol) for Alcon DRC?

The stock symbol (also called a 'ticker') for Alcon DRC is "A2LC34."

Does Alcon DRC Pay Dividends? What’s The Current A2LC34 Dividend Yield?

Yes, A2LC34 Pays Dividends to its Shareholders. The current Alcon DRC dividend yield is 0.3%%.

What Is the Current Alcon DRC Market Capitalisation?

As of today, Alcon DRC (B3: A2LC34) market cap is 214.36B BRL.

What Is Alcon DRC's (A2LC34) Earnings Per Share (TTM)?

The Alcon DRC EPS is currently 7.09 (Trailing Twelve Months).

How Many Times Has Alcon DRC Stock Split?

Alcon DRC has split 0 times. (See the A2LC34 stock split history page for full effective split date and price information.)

How Many Employees Does Alcon DRC Have?

Alcon DRC has 25000 employees, based on their latest Companies House report.

What is the current trading status of Alcon DRC (B3: A2LC34)?

As of 20/11/2026, Alcon DRC (A2LC34) is trading at a share price of 44.44 BRL, with a previous close of 44.44 BRL. The stock has fluctuated within a day range of 44.44 BRL to 44.56 BRL, while its 52-week range spans from 39.88 BRL to 44.56 BRL.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.